Wilmer Cutler Pickering Hale and Dorr has advised PTC Therapeutics, Inc. Davis Polk advised the representative of several initial purchasers. PTC Therapeutics, Inc., a publicly-traded global...
PTC Therapeutics Raises $550 Million in Convertible Notes Offering
Novartis Completes USD 11 Billion Multi-Tranche Notes Offering
Advestra and Davis Polk have advised Novartis AG and Novartis Capital Corporation. Novartis AG, together with its financing vehicle Novartis Capital Corporation, completed the successful placement...
Perspective Therapeutics Completes US$175 Million Equity Securities Offering
Hogan Lovells has advised Perspective Therapeutics. Davis Polk has advised the representatives of the underwriters. Perspective Therapeutics, Inc. has completed a US$175 million underwritten registered offering...
Terns Pharmaceuticals Completes $747.5 Million Public Offering of Common Stock
Wilmer Cutler Pickering Hale and Dorr has advised Terns Pharmaceuticals. Davis Polk has advised the representative of the underwriters. Terns Pharmaceuticals, Inc., a clinical-stage oncology company...
Beam Therapeutics’ $500 Million Common Stock Offering
Wilmer Cutler Pickering Hale and Dorr represented Beam Therapeutics Inc., and Davis Polk & Wardwell advised the underwriters in the offering. Beam Therapeutics Inc. (Nasdaq: BEAM)...
Ascentage Pharma’s $126.4 Million Initial Public Offering and Nasdaq Listing
Wilson Sonsini Goodrich & Rosati acted as U.S. and Hong Kong counsel to Ascentage Pharma on the offering, and Davis Polk & Wardwell advised the underwriters....
Terns Pharmaceuticals’ $172.7 Million IPO
Wilmer Cutler Pickering Hale and Dorr and Cooley advised on Terns Pharmaceuticals, Inc. on the offering, and Davis Polk & Wardwell advised the underwriters. Terns Pharmaceuticals,...
Eli Lilly’s $6.5 Billion Senior Notes Offering
Covington & Burling and Kirkland & Ellis acted as special counsel to Eli Lilly and Company, while Davis Polk & Wardwell advised the joint book-running managers...
Immunocore Holdings’ $402.5 Million Convertible Notes Offering
Davis Polk & Wardwell advised the several initial purchasers on the offering. Immunocore Holdings plc (Immunocore) (Nasdaq: IMCR) announced the pricing of $350.0 million aggregate principal amount...
Immatics’ $201 Million Follow-On Offering
Davis Polk & Wardwell advised Immatics N.V. on the offering, and Covington & Burling advised the underwriters. Immatics N.V. (Nasdaq: IMTX) announced its $201 million SEC-registered offering...
Merit Medical Systems’ $747.5 Million Convertible Senior Notes Offering
Davis Polk & Wardwell advised the representatives of the several initial purchasers on the offering. Merit Medical Systems, Inc. (Nasdaq: MMSI) (Merit) announced its $747.5 million of its...
actEvolent Health’s $402.5 Million Convertible Notes Offering
King & Spalding advised Evolent Health, Inc. on the offering, and Davis Polk & Wardwell advised the representative of the initial purchasers. Evolent Health, Inc. (NYSE:...